Shanghai General Healthy Information & Technology Co. Ltd. Class A

Shanghai General Healthy Information & Technology Co. Ltd. Class A

SSSE:605186
19.10
CNY
-0.85
(-4.26%)
0.21EPS
113.32P/E
3.35BMarket Cap
May 05Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.51
2.27
2.51
2.94
2.82
3.58
2.37
2.26
2.35
2.58
2.68
Basic EPS, GAAP
0.13
0.54
0.73
0.9
0.94
0.86
0.85
0.44
0.24
0.23
0.22
Free Cash Flow per Basic Share
0.39
0.55
0.43
-0.2
0.11
-0.2
-0.76
-0.53
-0.88
0.54
- -
Dividend per Share
0.14
- -
0.16
0.1
- -
0.21
0.09
0.09
0.12
0.03
0.03
Book Value per Share
53.84
1.19
1.92
2.82
5.98
6.63
7.39
7.74
7.88
8.11
8.15
Tangible Book Value per Share
53.74
1.19
1.74
2.65
5.86
6.51
7.28
7.55
7.6
7.85
7.02
Basic Weighted Avg Shares
136
103
102
102
102
137
136
136
136
134
130
Sales/Revenue/Turnover
205
233
256
300
287
490
322
308
318
345
350
Operating Margin (%)
28.25
36.64
41.43
41.59
45.26
30.38
41.02
30.39
10.87
16.85
12.88
Depreciation Expense
1
1
1
2
2
3
3
5
21
23
- -
Net Income, GAAP
18
55
75
92
96
118
116
60
33
31
28
Effective Tax Rate (%)
21.63
14.52
13.78
13.03
13.47
11.58
9.14
8.66
11.13
18.38
17.42
Profit Margin (%)
8.58
23.77
29.1
30.61
33.38
24.02
35.89
19.51
10.22
8.91
8.11
Working Capital
130
159
222
274
705
699
717
595
447
448
491
LT Debt
- -
- -
- -
43
- -
- -
- -
- -
- -
- -
46
Total Equity
160
178
256
351
878
976
1,083
1,138
1,161
1,186
1,215
Return on Invested Capital (%)
- -
36.1
36.97
31
16.77
13.77
11.81
5.71
2.9
2.17
2.07
Return on Capital (%)
- -
23.1
27.06
24.17
13.32
11.66
10.82
5.2
2.83
3.01
2.3
Return on Common Equity (%)
- -
46.48
47.11
38.03
17.39
13.72
12.14
5.83
3.06
2.83
2.6

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
125
122
129
LT Borrowings
- -
46
46
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
136
136
136
Market Capitalization
2,641
4,265
3,354

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
711
787
801
Cash, Cash Equivalents & STI
115
71
78
Accounts Receivable, Net
420
520
548
Inventories
89
116
108
Total Current Liabilities
274
307
310
Payables & Accruals
- -
- -
- -
ST Debt
125
122
129
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.29%
2.21%
Free Cash Flow
- -
-40.53%
-160.75%
Net Income, GAAP
- -
-15.61%
-5.34%
Sales/Revenue/Turnover
- -
8.8%
8.52%
Total Cash Common Dividend
- -
- -
-75.71%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36
110
50
123
318
2025
77
82
- -
75
345
2026
76
109
90
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.18
0.02
- -
0.24
2025
0.03
0.01
- -
0.16
0.23
2026
0.03
0.03
-0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.1
0.01
0.12
2025
0.01
0.01
- -
0.01
0.03
2026
0.01
0.01
0.01
- -
- -

Company Description

CEO
Jian Wei Dai
Full Time Employees
337
Sector
Health technology
Industry
Medical specialties
Address
No. 518, Zhongchen Road Shanghai SH China 201613
IPO Date
Dec 22, 2020
Business
Shanghai General Healthy Information and Technology Co., Ltd. is a China-based technology-driven company specializing in pharmaceutical logistics automation, information technology, intelligent manufacturing, and mobile medical solutions. Founded in 2014 and headquartered in Shanghai, the company designs, develops, and sells a comprehensive range of products including automatic dispensing machines, smart drug management cabinets, intelligent access shelves, automatic drug configuration robots, and related applications. Its core business segments include smart pharmacy projects, intelligent dispensing centers, pharmaceutical consumables management, logistics automation, and mobile robotics, servicing hospitals, retail pharmacies, and pharmaceutical circulation industries across China. Recent strategic developments include expanding its business scope beyond hospital applications to new retail pharmacies and mobile healthcare sectors, signaling a broader market penetration and integration of intelligent medical logistics with emerging healthcare delivery models. The company continues to advance its technology leadership with innovations such as chute dispensing technology and the integration of vision and robotics technology into pharmaceutical automation, reinforcing its competitive edge as a pioneer in these domains. It has also begun gaining international experience and initiated steps toward global expansion. Shanghai General Healthy operates within the growing Chinese healthcare market, responding to ongoing reforms that emphasize digital health, cost control, and modernization of pharmaceutical services. The firm's offerings target a wide range of customers including public and private medical institutions, retail pharmacies, and pharmaceutical supply chains. The company maintains a low asset-liability ratio and invests in technology-driven solutions to support intelligent drug management, intravenous admixture services, and medicine and consumables management. It remains positioned as a leading integrated solutions provider in pharmaceutical logistics automation and smart medical technologies in China.